mTOR inhibitors have been proven to improve the efficacy of chemotherapy and radiotherapy without increasing adverse effects by preventing lactate production and inhibiting HNSCC cell proliferation.315 In an orthotopic xenograft model of HNSCC, temsirolimus, a potent mTOR inhibitor, exhibited effects on tumor growth. Here, MTOR is linked to head and neck squamous cell carcinoma.